These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16724576)

  • 1. Simultaneous administration of vardenafil and alcohol does not result in a pharmacodynamic or pharmacokinetic interaction in healthy male subjects.
    Wensing G; Bauer R; Unger S; Rohde G; Heinig R
    Int J Clin Pharmacol Ther; 2006 May; 44(5):216-24. PubMed ID: 16724576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
    Auerbach SM; Gittelman M; Mazzu A; Cihon F; Sundaresan P; White WB
    Urology; 2004 Nov; 64(5):998-1003; discussion 1003-4. PubMed ID: 15533493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose.
    Stark S; Sachse R; Liedl T; Hensen J; Rohde G; Wensing G; Horstmann R; Schrott KM
    Eur Urol; 2001 Aug; 40(2):181-8; discussion 189-90. PubMed ID: 11528196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction.
    Rajagopalan P; Mazzu A; Xia C; Dawkins R; Sundaresan P
    J Clin Pharmacol; 2003 Mar; 43(3):260-7. PubMed ID: 12638394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study.
    Klotz T; Sachse R; Heidrich A; Jockenhövel F; Rohde G; Wensing G; Horstmann R; Engelmann R
    World J Urol; 2001 Feb; 19(1):32-9. PubMed ID: 11289568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials.
    Heinig R; Weimann B; Dietrich H; Böttcher MF
    Clin Drug Investig; 2011; 31(1):27-41. PubMed ID: 20925442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vardenafil allows successful intercourse initiated rapidly after dosing in Japanese patients with diabetes mellitus and erectile dysfunction.
    Nagao K; Kobayashi H; Fujikawa K; Tachibana T; Iwamoto Y; Ishii N; Turek PJ; Brant WO; Kamidono S
    J Sex Med; 2009 Oct; 6(10):2851-7. PubMed ID: 19732311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials.
    Sperling H; Gittelman M; Norenberg C; Ulbrich E; Ewald S
    J Sex Med; 2011 Jan; 8(1):261-71. PubMed ID: 20807322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations.
    Debruyne FM; Gittelman M; Sperling H; Börner M; Beneke M
    J Sex Med; 2011 Oct; 8(10):2912-23. PubMed ID: 21883954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effective and safe use of Levitra (Vardenafil) for treatment of erectile dysfunction].
    Mazo EB; Gamidov SI; Ovchinnikov RI
    Urologiia; 2004; (3):58-66. PubMed ID: 15199819
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of food and alcohol on the pharmacokinetics of vardenafil].
    He ZJ
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):477-9. PubMed ID: 15999499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
    Sperling H; Debruyne F; Boermans A; Beneke M; Ulbrich E; Ewald S
    J Sex Med; 2010 Apr; 7(4 Pt 1):1497-507. PubMed ID: 20233275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacodynamics and pharmacokinetics of vardenafil in patients with erectile dysfunction].
    Jin J; Guo Y
    Zhonghua Nan Ke Xue; 2004 Sep; 10(9):711-6. PubMed ID: 15497717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.
    Lubamba B; Lecourt H; Lebacq J; Lebecque P; De Jonge H; Wallemacq P; Leal T
    Am J Respir Crit Care Med; 2008 Mar; 177(5):506-15. PubMed ID: 18006891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction.
    Ziegler D; Merfort F; Van Ahlen H; Yassin A; Reblin T; Neureither M
    J Sex Med; 2006 Sep; 3(5):883-891. PubMed ID: 16942532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vardenafil improved erectile function in a "real-life" broad population study of men with moderate to severe erectile dysfunction in Australia and New Zealand.
    McMahon C; Lording D; Stuckey B; Tan V; Gillman M; White W; Di Natale S; Bramwell P
    J Sex Med; 2006 Sep; 3(5):892-900. PubMed ID: 16942533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.
    Goldstein I; Young JM; Fischer J; Bangerter K; Segerson T; Taylor T;
    Diabetes Care; 2003 Mar; 26(3):777-83. PubMed ID: 12610037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
    Rubio-Aurioles E; Porst H; Eardley I; Goldstein I
    J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac factors affecting the success of vardenafil in erectile dysfunction.
    Zengin K; Ede H; Tanik S; Albayrak S; Sarikaya S; Erbay A; Imamoğlu MA; Gürdal M
    Turk J Med Sci; 2015; 45(4):751-7. PubMed ID: 26422841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.